Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Otsuka Holdings Co ( (JP:4578) ) just unveiled an announcement.
Otsuka Holdings has completed the payment process for the disposal of 83,920 treasury shares, which were issued as restricted stock compensation to directors of the company and its subsidiaries. The transaction, valued at approximately ¥930.7 million at ¥11,090 per share, strengthens Otsuka’s equity-based compensation framework and further aligns management incentives with shareholder interests.
Under the plan, eight directors of the parent company, excluding outside directors, received a total of 38,500 shares, while 35 directors of subsidiaries received 45,420 shares. By expanding restricted stock awards across its leadership structure, Otsuka may enhance long-term commitment among key executives and reinforce governance practices that tie management rewards to corporate performance.
The most recent analyst rating on (JP:4578) stock is a Buy with a Yen12500.00 price target. To see the full list of analyst forecasts on Otsuka Holdings Co stock, see the JP:4578 Stock Forecast page.
More about Otsuka Holdings Co
Otsuka Holdings Co., Ltd. is a Japan-based healthcare company listed on the Prime Market of the Tokyo Stock Exchange, active in pharmaceuticals and related businesses. The group focuses on developing and commercializing medical and health products, with its operations overseen by a board that includes directors at both the parent company and its subsidiaries.
Average Trading Volume: 1,285,159
Technical Sentiment Signal: Buy
Current Market Cap: Yen5734.5B
Learn more about 4578 stock on TipRanks’ Stock Analysis page.

